Papers
23
Total Citations
719
H-Index
13
About
Fabio Crocerossa is a leading urologic surgeon and researcher whose work has fundamentally advanced the field of robotic surgery. His primary research focuses on the comparative effectiveness and long-term outcomes of robot-assisted procedures for kidney cancer, prostate cancer, and benign prostatic hyperplasia. Crocerossa’s major contributions include landmark meta-analyses and multicenter studies that have established the superiority of robotic approaches over traditional laparoscopic techniques. His 2020 systematic review on robot-assisted radical nephrectomy (118 citations) and his 2021 analysis of robot-assisted radical prostatectomy (84 citations) are widely cited benchmarks. He has also pioneered work on complex partial nephrectomies, including a 2020 multicenter analysis of completely endophytic tumors (62 citations) and a 2022 multimodel study predicting renal function decline after surgery (42 citations). As a key member of the ROBUUST collaborative group, Crocerossa led a 2022 propensity-score matched analysis of robotic versus laparoscopic nephroureterectomy (58 citations), demonstrating superior outcomes. His research has been instrumental in shaping clinical guidelines and surgical practice, making him a highly influential voice in the era of robotic urology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5Robot-assisted partial nephrectomy: 7-year outcomes60 citations · 2021
- 6
- 7
- 8
- 9
- 10New robotic surgical systems in urology: an update22 citations · 2020